Perfusion! Jeopardy or the Ultimate Advantage?

BioProcess International

Home | Downstream | Upstream | Manufacturing | Archive

Webcast Information

Perfusion! Jeopardy or the Ultimate Advantage?

In the past, perfusion methods were known to have high failure rates, but improvements in the technology have made perfusion more reliable. With newly improved technology and equipment, perfusion is now an efficient manufacturing process with the ability to reduce the cost of goods and capital investment required to bring a drug to market. In this on-demand educational webcast, Dr. Jason N. Carstens of CMC Biologics discusses:

A Comparison Between Perfusion and Fed-Batch Methods
Detailed Description of Perfusion Operations
Advantages and Challenges of Perfusion

Join Dr. Carstens as he displaces old myths about perfusion and shows how this method of manufacturing can actually produce proteins that have more desirable product efficacy and safety profiles than would be possible with the fed-batch method.

Targeted BPI Content

A Single-Use, Scalable Perfusion Bioreactor System
BioProcess International, June 2009
Learn more.

A Bioreactor System Based on a Novel Oxygen Transfer Method
BioProcess International, June 2008
Learn more.

Determining the Effect of Raw Materials on Manufacturing-Scale Cell-Culture Performance
An Application of Mechanistic Mathematical Models
BioProcess International, June 2008
Learn more.

A Review of Therapeutic Protein Expression By Mammalian Cells
BioProcess International, June 2008
Learn more.

Analytical Technology and PAT
BioProcess International, January 2007
Learn more.

Bioreactor Monitoring, Modeling, and Simulation
BioProcess International, January 2007
Learn more.

Whole-Genome Evolution Technology
Improving Protein and Antibody Yields in Scalable Mammalian-Cell-Based Manufacturing
BioProcess International, May 2006
Learn more.